Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus
出版年份 2011 全文链接
标题
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume 29, Issue 11, Pages 993-1003
出版商
Springer Nature
发表日期
2011-11-09
DOI
10.1038/nbt.2020
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b
- (2013) Donald M. Jensen ANNALS OF INTERNAL MEDICINE
- Promising Targets for Anti-Hepatitis C Virus Agents
- (2011) T. Yoshida et al. CURRENT MEDICINAL CHEMISTRY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- 415 TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN INCREASED SUSTAINED VIROLOGIC RESPONSE RATES IN TREATMENT-NAIVE PATIENTS REGARDLESS OF RACE OR ETHNICITY
- (2011) G.M. Dusheiko et al. JOURNAL OF HEPATOLOGY
- Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus
- (2011) K. Morikawa et al. JOURNAL OF VIRAL HEPATITIS
- The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naïve patients
- (2011) David R. Nelson LIVER INTERNATIONAL
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- New HCV therapies on the horizon
- (2010) J. Vermehren et al. CLINICAL MICROBIOLOGY AND INFECTION
- Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
- (2010) Patrick Marcellin et al. GASTROENTEROLOGY
- Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study
- (2010) Savino Bruno et al. HEPATOLOGY
- Institute of Medicine recommendations for the prevention and control of hepatitis B and C
- (2010) Abigail E. Mitchell et al. HEPATOLOGY
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Therapies for Chronic Hepatitis C
- (2010) McKenzie C Ferguson PHARMACOTHERAPY
- Mixing the right hepatitis C inhibitor cocktail
- (2010) Michael A. Gelman et al. TRENDS IN MOLECULAR MEDICINE
- Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
- (2010) Leen Delang et al. Viruses-Basel
- A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
- (2010) Bambang S. Adiwijaya et al. PLoS Computational Biology
- Telaprevir: Hope on the Horizon, Getting Closer
- (2009) Ilan S. Weisberg et al. Clinics in Liver Disease
- Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2009) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Serine protease inhibitors as anti-hepatitis C virus agents
- (2009) Markus Reiser et al. Expert Review of Anti-Infective Therapy
- Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
- (2009) Thierry Poynard et al. GASTROENTEROLOGY
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results
- (2009) Bruce R. Bacon et al. HEPATOLOGY
- Public health impact of antiviral therapy for hepatitis C in the United States
- (2009) Michael L. Volk et al. HEPATOLOGY
- Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
- (2009) T. L. Kieffer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Step Forward in Therapy for Hepatitis C
- (2009) Jay H. Hoofnagle NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients
- (2008) Eric Lawitz et al. JOURNAL OF HEPATOLOGY
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now